Overall and lymphoma-specific mortality based on the TRES score and NHL subtype
| Subtype . | N . | Cumulative mortality at 3-years . | N . | Cumulative lymphoma-specific mortality at 3-years . | Log-rank test . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| TRES score 0, n % . | TRES score 1, n % . | TRES score 2-3, n % . | Log-rank test . | TRES score 0, n % . | TRES score 1, n % . | TRES score 2-3, n % . | ||||
| DLBCL | 11 154 | 41.7 | 53.0 | 63.5 | P < .001 | 8292 | 31.2 | 37.8 | 43.5 | P < .001 |
| FL | 5087 | 15.4 | 25.5 | 33.9 | P < .001 | 3870 | 8.8 | 14.2 | 17.4 | P < .001 |
| Marginal zone lymphoma | 3647 | 16.3 | 24.0 | 31.7 | P < .001 | 2597 | 7.7 | 8.4 | 10.8 | P = .068 |
| Mantle cell lymphoma | 1565 | 35.0 | 47.2 | 56.3 | P < .001 | 1208 | 25.5 | 32.3 | 33.3 | P = .076 |
| Lymphoplasmacytic lymphoma | 651 | 16.6 | 23.1 | 40.8 | P < .001 | 495 | 6.4 | 5.0 | 14.0 | P = .329 |
| CLL | 11 406 | 19.7 | 27.8 | 39.1 | P < .001 | 8368 | 6.4 | 8.1 | 10.0 | P = .015 |
| Peripheral T-cell lymphoma | 1136 | 57.0 | 68.0 | 74.6 | P < .001 | 851 | 46.7 | 52.5 | 49.6 | P = .327 |
| Cutaneous T-cell lymphoma | 1051 | 19.4 | 29.4 | 41.8 | P < .001 | 773 | 10.6 | 15.2 | 20.7 | P = .024 |
| Subtype . | N . | Cumulative mortality at 3-years . | N . | Cumulative lymphoma-specific mortality at 3-years . | Log-rank test . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| TRES score 0, n % . | TRES score 1, n % . | TRES score 2-3, n % . | Log-rank test . | TRES score 0, n % . | TRES score 1, n % . | TRES score 2-3, n % . | ||||
| DLBCL | 11 154 | 41.7 | 53.0 | 63.5 | P < .001 | 8292 | 31.2 | 37.8 | 43.5 | P < .001 |
| FL | 5087 | 15.4 | 25.5 | 33.9 | P < .001 | 3870 | 8.8 | 14.2 | 17.4 | P < .001 |
| Marginal zone lymphoma | 3647 | 16.3 | 24.0 | 31.7 | P < .001 | 2597 | 7.7 | 8.4 | 10.8 | P = .068 |
| Mantle cell lymphoma | 1565 | 35.0 | 47.2 | 56.3 | P < .001 | 1208 | 25.5 | 32.3 | 33.3 | P = .076 |
| Lymphoplasmacytic lymphoma | 651 | 16.6 | 23.1 | 40.8 | P < .001 | 495 | 6.4 | 5.0 | 14.0 | P = .329 |
| CLL | 11 406 | 19.7 | 27.8 | 39.1 | P < .001 | 8368 | 6.4 | 8.1 | 10.0 | P = .015 |
| Peripheral T-cell lymphoma | 1136 | 57.0 | 68.0 | 74.6 | P < .001 | 851 | 46.7 | 52.5 | 49.6 | P = .327 |
| Cutaneous T-cell lymphoma | 1051 | 19.4 | 29.4 | 41.8 | P < .001 | 773 | 10.6 | 15.2 | 20.7 | P = .024 |